Ethypharm agrees to acquire Martindale Pharma
Acquisition19/01/2017
Ethypharm announced a definitive agreement to acquire UK specialty pharmaceutical company Martindale Pharma. The proposed combination broadened the group’s position in opioid addiction, emergency care and sterile injectables, adding manufacturing capabilities across solid dosage forms, injectables and oral liquids. The company’s subsequent history records Martindale as a 2017 acquisition. This entry uses the agreement announcement date, not an invented closing date, and describes a group acquisition rather than assuming the acquiring legal subsidiary. No transaction consideration was disclosed in the cited release.
Type
Acquisition
Announced
19/01/2017
Amount
Financial data requires access